Stay updated on Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.

Latest updates to the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has removed detailed information about a clinical study for advanced dedifferentiated liposarcoma, including participant eligibility and treatment protocols, while adding a new EudraCT number and a revision number.SummaryDifference22%
- Check34 days agoChange DetectedThe page has updated the date from March 25, 2025, to March 24, 2025, and has changed the status from 'No Results Posted' to 'Results Submitted'.SummaryDifference0.3%
- Check41 days agoChange DetectedThe page has been updated to reflect a new version, v2.14.3, with the last update date changed to March 25, 2025. The previous version, v2.14.2, and its last update date of March 24, 2025, have been removed.SummaryDifference0.1%
- Check48 days agoChange DetectedThe page has updated the dates related to the trial and clarified the definition of the best overall response, including additional conditions for patient participation.SummaryDifference0.4%
- Check63 days agoChange DetectedThe page has updated its dates, adding new ones for March and November 2025 while removing older dates from January 2025 and May 2026. Additionally, the reference to 'Hospital Vall d'Hebron' has been simplified by removing the specific address.SummaryDifference0.6%
Stay in the know with updates to Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.